GLP1R and type 2 diabetes mellitus: Currently, GLP-1 receptor agonist (GLP-1RAs), such as liraglutide, are being used clinically and can effectively reduce fasting blood glucose levels, postprandial blood glucose levels, weight, and glycated hemoglobin (HbA1c) levels in T2DM patients (Yao et al., 2024).